NCT02669914 - MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

September 21, 2017

Study Completion Date

January 11, 2018

Conditions

Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast CancerCancer of BreastCancer of the BreastGastroesophageal CancerPancreatic CancerCancer of the PancreasColorectal CancerColorectal CarcinomaRenal CancerKidney CancerCancer of the KidneyCancer of KidneyOvarian CancerOvary CancerCancer of the OvaryCancer of Ovary

Interventions

DRUG

MEDI4736

Trial Locations (1)

63110

Washington University School of Medicine, St Louis